Document is current
Any future updates will be listed below
-
Authors
Hitzenbichler, Florian
Fisser, Christoph
Schlitt, Alexandra
Salzberger, Bernd
-
Funding
Funding for this research was provided by:
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 23 September 2024
First Online: 14 October 2024
Declarations
:
: Possible conflincts of interest are included in the manuscript of the case report.
: Florian Hitzenbichler: Travel grants from Gilead Sciences, Tillotts Pharma. Lecture fees from MSD Sharp & Dohme, Pfizer. Bernd Salzberger: no conflicts of interest. Christoph Fisser: Travel grants and lecture fees from AstraZeneca, Berlin-Chemie, Chiesi, CSL Behring and Novartis. Alexandra Schlitt: no conflicts of interest.
